Skip to main content

Apolipoprotein ϵ4 status is associated with behavioral symptoms in nursing home residents with dementia

  • Diana Lynn Woods (a1), Brittany Bushnell (a1), Haesook Kim (a1), Daniel Geschwind (a2) and Jeffrey Cummings (a3)...

Background: While the relationship of apolipoprotein E (APOE) to behavioral symptoms of dementia (BSD) has been studied in community-dwelling persons with AD, it has received limited attention within the nursing home (NH) population. The aim of this study was to examine the association between APOE genotype and BSD in NH residents using direct observation.

Methods: Thirty-six participants, aged 71–102 years, were compared using a non-randomized two-group design with continuous measures. APOE genotype was obtained by buccal swab. BSD, including restlessness, escape restraint, tapping and banging, searching and wandering, pacing and walking, and vocalization, were measured using the Modified Agitated Behavior Rating Scale. Participants were observed every 20 minutes for 12 hours per day for five days. Each participant's mean behavior scores were compared according to the presence or absence of the APOE ϵ4 allele.

Results: Resident characteristics included a mean MMSE of 10.44 indicating moderate to severe dementia and a mean of 3.44 medical co-morbidities. Fifty-six percent of the participants had one ϵ4 allele. A significant difference was found between APOE ϵ4+/4− and mean behavioral scores (F1,31 = 4.40, p = 0.04). Restlessness was significantly inversely correlated with MMSE (r = −0.367, p = 0.03), but not APOE genotype. There was no significant correlation between proxy reporting and direct observation (r = 0.257, p = 0.13).

Conclusion: Findings indicate that the presence of the APOE ϵ4+ genotype increases the risk for BSD in NH residents with dementia. Direct observation proved a more accurate estimate of BSD than proxy report.

Corresponding author
Correspondence should be addressed to: Diana Lynn Woods, Assistant Professor, University of California, Los Angeles, School of Nursing, 700 Tiverton Avenue, Box 956919, Los Angeles, CA 90095-6919, U.S.A. Phone: + 1 310 206-5457; Fax: +1 310 206-3241. Email:
Hide All
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: American Psychiatric Association.
Beck C. et al. (1998). Correlates of disruptive behavior in severely cognitively impaired nursing home residents. Gerontologist, 38, 189198.
Bedford S., Melzer D. and Guralnik J. (2001). Problem behavior in the last year of life: prevalence, risks, and care receipt in older Americans. Journal of the American Geriatrics Society, 49, 590595.
Brooke V. (1989). Nursing home life: how elders adjust. Geriatric Nursing, 10, 6668.
Cariaga J., Burgio L., Flynn W. and Martin D. (1991). A controlled study of disruptive vocalizations among geriatric residents in nursing homes. Journal of the American Geriatrics Society, 39, 501507.
Caselli R. J., Reiman E. M., Hentz J. G., Osborne D. and Alexander G. E. (2004). A distinctive interaction between chronic anxiety and problem solving in asymptomatic APOE e4 homozygotes. Journal of Neuropsychiatry and Clinical Neurosciences, 16, 320329.
Cohen-Mansfield J. (1986). Agitated behaviors in the Elderly: II. Preliminary results in the cognitively deteriorated. Journal of the American Geriatrics Society, 34, 722727.
Cohen-Mansfield J. and Libin A. (2004). Assessment of agitation in elderly patients with dementia: correlations between informant rating and direct observation. International Journal of Geriatric Psychiatry, 19, 881891.
Cohen-Mansfield J. and Werner P. (1998). Predictors of aggressive behaviors: a longitudinal study in senior day care centers. Journal of Gerontology, B: Psychological Science Social Science, 53, 300310.
Corder E. H. et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921923.
Craig D., Hart D. J., McCool K., McIlroy S. P. and Passmore A. P. (2004). Apolipoprotein E e4 allele influences aggressive behavior in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 75, 13271330.
Davignon J., Cohn J. S., Mabile L. and Bernier L. (1999). Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clinica Chimica Acta, 286, 115143.
Eichner J., Dunn S., Perveen G., Thompson D., Stewart K. and Stroehla B. (2002). Apolipoprotein E polymorphism and cardiovascular disease: a human genome epidemiology review. American Journal of Epidemiology, 155, 487495.
Evans D. A. et al. (1997). Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA, 277, 822824.
Finkel S. I., Lyons J. and Anderson R. L. (1993). A brief agitation rating scale (BARS) for nursing home elderly. Journal of the American Geriatrics Society, 41, 5052.
Folstein M. F., Folstein S. E. and McHugh P. R. (1975). Mini mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.
Gabryelewicz T. et al. (2002). Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype. Dementia and Geriatric Cognitive Disorders, 14, 208212.
Haan M. N., Shemanski L., Jagust W. J., Manolio T. A. and Kuller L. (1999). The role of APOE ϵ4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA, 282, 4046.
Katz S. and Akpom C. A. (1976). Index of ADL. Medical Care, 14, 116118.
Kolovou G. and Anagnostopoulou K. (2007). Apolipoprotein E polymorphism, age and coronary heart disease. Ageing Research Review, 6, 94108.
Kozauer N. A., Mielke M. M., Chan G. K., Rebok G. W. and Lyketsos C. G. (2008). Apolipoprotein E genotype and lifetime cognitive decline. International Psychogeriatrics, 20, 109123.
Mahley R. W. and Rall S. C. Jr. (1999). Is epsilon4 the ancestral human apoE allele? Neurobiology of Aging, 20, 429430.
Raber J. (2007). Role of apolipoprotein E in anxiety. Neural Plasticity, 2007, doi: 10.1155/2007/91236
Robertson J., Curley J., Kaye J., Quinn J., Pfankuch T. and Raber J. (2005). apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice. Neurobiology of Aging, 26, 637643.
Scarmeas N. et al. (2002). Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology, 58, 11821188.
Shrout P. E. and Fleiss J. L. (1979). Intraclass correlations: uses in assessing rater reliability. Psychological Bulletin, 86, 420428.
van der Flier W. M. et al. (2007). Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dementia and Geriatric Cognitive Disorder, 23, 4246.
Vertesi A. et al. (2001). Standardized Mini-mental State Examination: use and interpretation. Canadian Family Physician, 47, 20182023.
Woods D. L. and Dimond M. (2002). The effect of therapeutic touch on agitated behavior and cortisol in persons with Alzheimer's disease. Biological Research for Nursing, 4, 104114.
Woods D. L., Kovach C. R., Raff H., Joosse L., Basmadjian A. and Hegadoren K. M. (2008). Using saliva to measure endogenous cortisol in nursing home residents with advanced dementia. Research in Nursing and Health, 31, 283294.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 2
Total number of PDF views: 12 *
Loading metrics...

Abstract views

Total abstract views: 117 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th November 2017. This data will be updated every 24 hours.